Barcelona hosted the 23rd EuroMedLab Congress, the most important scientific event for Laboratory Medicine in Europe, from May 19 to 23
Barcelona hosted the 23rd EuroMedLab Congress, the most important scientific event for Laboratory Medicine in Europe, from May 19 to 23 at the CCIB (International Convention Center of Barcelona).
Organized by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) and the Spanish Society of Laboratory Medicine (SEQCML), this biennial meeting was an opportunity to show the latest advances in research and clinical science in the various areas of Laboratory Medicine.
With 1,563 communications received from 83 different countries, the communications record from previous editions has been broken, with notable contributions from Spanish professionals, given that one in three communications were sent by professionals from our country.
More than 100 speakers from numerous countries around the world participated, including 33 Spaniards, with a very high scientific level addressing current issues in the different disciplines of Laboratory Medicine, such as clinical biochemistry, hematology, microbiology, immunology, and molecular biology.
The total number of attendees exceeded 6,000 professionals, including congress registrants and visitors to the commercial exhibition, which is a new record compared to previous editions.
Likewise, the Congress included more than 70 scientific activities distributed over four plenary sessions, in addition to 20 symposiums, seven monographic sessions, 40 educational workshops, and an inaugural conference in which Dr. Manuel Serrano, leader of the Laboratory of Cellular Plasticity and Disease of the IRB Barcelona, addressed advances in understanding of the mechanisms of aging and senescent cells and their possible clinical applications, with the paper entitled Recent Progress on the Mechanisms of Aging and its Medical Applications.
In addition, among the topics covered during the five days of the Congress were epigenetics applied to cancer, the microbiome, big data and information security, CRISPR, diabetes, kidney, liver and thyroid diseases, sepsis, in vitro fertilization, cerebrovascular and cardiac disease, personalized immunosuppression, congenital metabolic errors, non-invasive prenatal tests through the analysis of circulating fetal DNA, and dyslipidemia. Likewise, there was time to discuss issues related to professional and organizational development, quality in the clinical laboratory based on the 20-year experience of the Spanish Society of Laboratory Medicine, point-of-care-testing, professional development for young scientists, and aspects of regulation from new legislation at the European level.
For its part, and as part of the Congress activity, the Spanish Society of Laboratory Medicine also carried out two satellite symposiums in advance. The first of them on Quality and Laboratory Medicine, and more specifically on the updating of the Biological Variation data table and its use to ensure the clinical usefulness of laboratory results. And the second focused on standardization in the hematology laboratory, and which shared the challenges facing the clinical laboratory in detecting these diseases in an increasingly globalized world, highlighting the importance of consensus on the values analyzed and the need to use optical means to detect some pathologies.
During the Congress there was also a large commercial exhibition where 42 in vitro diagnostic companies presented their latest developments related to Laboratory Medicine. Congress attendees had the opportunity to interact with their colleagues and professionals from other countries.
In addition, coinciding with the Congress, numerous meetings of the various working groups of the societies organizing the Congress were held, with a high participation of professionals.
Both the scientific program and the activities presented, and the high level of participation, give good proof of the success of the celebration of the 23rd EuroMedLab Congress in Barcelona.
This success has been possible thanks to the effort, work, and enthusiasm of many professionals of the SEQCML who for more than two years have participated in both the organizational and scientific parts of the Congress.
"We must be proud that at the international level they have trusted us to carry out this Congress, 16 years after the only time it had been held in Spain. Precisely because of this, it has been a great challenge and responsibility to carry it out impeccably, taking care of each and every detail at a scientific and organizational level," concluded Dr. Imma Caballé, president of the Congress and the SEQCML.